PubMed, enrolling/recruiting trials, guidelines Clinical Guidance, Healio CME, FDA news Healio's exclusive daily news coverage of clinical data Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on
Clinical research, including the STEP 1 trial, shows that up to 40% of the weight lost on semaglutide (Ozempic) is from lean mass
Youve probably heard about the wonder drugs, Ozempic and Wegovy, which are taken by millions of people worldwide to treat diabetes and obesity
Both approaches achieve similar results
Semaglutide, by contrast, does not carry the same acute hypoglycemia risk when injected too deeply, unless combined with other blood sugar-lowering medications